1st-of-its-kind Phase I trial will treat MS patients with their own stem cells August 15, 2013 By Sony Salzman Leave a Comment The FDA gave New York’s Tisch MS Research Center a green-light to move forward with a 1st-of-its-kind Phase I investigational new drug trial that will aim to treat multiple sclerosis with a direct spine injection of the patient’s own stem cells.